Thursday, 27 August 2026
PERSPECTA
News from every angle
All
Stream
World
Politics
Business
Technology
Finance
Science
Health
Culture
Opinion
Environment
← Back to headlines
Ovid Therapeutics advances OV329 epilepsy drug, secures $60M financing
18 Mar, 10:35 — 18 Mar, 10:35
Post
Share
Copy link
Embed
Sources
Sort: Relevance
Sort: Latest
Sort: Bias (L→R)
Sort: Bias (R→L)
Sort: Factuality
left
center
right
Showing 1 of 1 sources
seeking-alpha
Mixed
162d ago
Ovid Therapeutics advances OV329 epilepsy drug, secures $60M financing
Read full article →
Something wrong with this story? Report an issue
Related Stories
U.S. FDA Approves Landmark Pancreatic Cancer Drug With Improved Survival Rates
35m ago
West Nile Virus Outbreaks Spread Across Greece and North Macedonia
1h ago
Kylie Jenner Reveals Plans for Larger Breast Implants
1h ago
World Health Organization Declares Uganda Ebola Outbreak Over
2h ago
Thursday, 27 August 2026
Explore
Log in
Sign up
en
PERSPECTA
News from every angle
